Robotic Ankle Therapy for Cerebral Palsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests new robotic ankle devices to help children with cerebral palsy (CP) improve their walking. Researchers compare the effects of robotic ankle resistance and assistance (Biomotum Spark) against standard therapies to determine which works best. They examine how these devices might enhance muscle control, gait, and overall mobility. Children with CP who have ankle-related walking issues and can walk at least 30 feet might be suitable candidates. The study aims to find better ways to boost movement and endurance during everyday activities. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the chance to be among the first to receive this innovative therapy.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications, but it does mention that you cannot have concurrent treatment other than those assigned during the study. It's best to discuss your specific medications with the trial coordinators.
What prior data suggests that this robotic ankle therapy is safe for children with cerebral palsy?
Research shows that robotic ankle devices, such as the Biomotum Spark, have been tested to assist people with cerebral palsy. Studies have found that these devices can improve walking and ease movement. Initial tests of the Biomotum Spark's robotic ankle support demonstrated that users experienced better mobility and found walking on various surfaces, like flat ground and stairs, less tiring.
Regarding the robotic ankle's resistance feature, past research focused on ensuring its safety and effectiveness. Tests aimed to enhance overall walking and movement. These tests found that the devices were generally well-received, with no major safety issues.
Since this trial is in the early stages, it primarily assesses the treatment's safety and how well people adapt to it. At this point, researchers closely monitor any new treatment to ensure it doesn’t cause harm, but there is limited information on long-term effects. Participants can expect a thorough evaluation to ensure safety.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these robotic ankle therapies for cerebral palsy because they offer a new approach to improving mobility. Unlike traditional physical therapy and ankle braces, which primarily support or stabilize the ankle, the Biomotum Spark device provides both adaptive assistance and resistance during movement. This means it can dynamically help or challenge the muscles, potentially enhancing muscle strength and coordination more effectively. By targeting specific muscle groups with precision, these treatments aim to improve walking ability in ways that standard treatments may not.
What evidence suggests that this trial's treatments could be effective for cerebral palsy?
Research shows that robotic ankle support can significantly improve mobility for people with cerebral palsy. In this trial, participants may use the Biomotum Spark device, which offers both support and resistance. Studies have found that this technology eases walking and reduces fatigue by lowering ankle strain by 12%, especially when walking uphill. Additionally, robotic ankle resistance training can enhance walking speed, distance, and step length. This approach helps build muscle strength and improve walking patterns. The Biomotum Spark device aims to enhance strength and movement skills, showing promising early results for children with CP.13678
Who Is on the Research Team?
Zach F Lerner, PhD
Principal Investigator
Northern Arizona University
Are You a Good Fit for This Trial?
This trial is for children aged 8-18 with Cerebral Palsy who have trouble walking due to ankle issues. They must be able to follow simple instructions and walk at least 30 feet, with or without help. Kids who've had other treatments or surgeries within the last 6 months can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo targeted ankle resistance gait training and adaptive ankle assistance for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Ankle foot orthosis
- Biomotum Spark: Robotic ankle assistance
- Biomotum Spark: Robotic ankle resistance
- Standard gait training
- Standard physical therapy
- Standard walking
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northern Arizona University
Lead Sponsor
University of Washington
Collaborator
Gillette Children's Specialty Healthcare
Collaborator